Perspectives in allergen immunotherapy: 2019 and beyond
Open Access
- 30 November 2019
- Vol. 74 (S108), 3-25
- https://doi.org/10.1111/all.14077
Abstract
The seventh "Future of the Allergists and Specific Immunotherapy (FASIT)" workshop held in 2019 provided a platform for global experts from academia, allergy clinics, regulatory authorities and industry to review current developments in the field of allergen immunotherapy (AIT). Key domains of the meeting included the following: (a) Biomarkers for AIT and allergic asthma; (b) visions for the future of AIT; (c) progress and data for AIT in asthma and the updates of GINA and EAACI Asthma Guidelines (separated for house dust mite SCIT, SLIT tablets and SLIT drops; patient populations) including a review of clinically relevant endpoints in AIT studies in asthma; (d) regulatory prerequisites such as the "Therapy Allergen Ordinance" in Germany; (e) optimization of trial design in AIT clinical research; (f) challenges planning and conducting phase III (field) studies and the future role of Allergen Exposure Chambers (AEC) in AIT product development from the regulatory point of view. We report a summary of panel discussions of all six domains and highlight unmet needs and possible solutions for the future.Keywords
Funding Information
- ALLERGOPHARMA GmbH & Co. KG
This publication has 91 references indexed in Scilit:
- Placebo analgesia: Psychological and neurobiological mechanismsPain, 2013
- SQ-standardized sublingual grass immunotherapy: Confirmation of disease modification 2 years after 3 years of treatment in a randomized trialJournal of Allergy and Clinical Immunology, 2012
- Prospective validation of the “rhino conjunctivitis allergy‐control‐SCORE©” (RC‐ACS©)Clinical and Translational Allergy, 2012
- Lebrikizumab Treatment in Adults with AsthmaNew England Journal of Medicine, 2011
- Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollenAllergy and Asthma Proceedings, 2011
- Prospective validation of ‘Allergy-Control-SCORETM’: a novel symptom-medication score for clinical trialsAllergy, 2011
- Injection allergen immunotherapy for asthmaCochrane Database of Systematic Reviews, 2010
- Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: Olopatadine hydrochloride versus mometasone furoate monohydrateAllergy and Asthma Proceedings, 2007
- Worldwide trends in the prevalence of asthma symptoms: phase III of the International Study of Asthma and Allergies in Childhood (ISAAC)Thorax, 2007
- Allergen-specific immunotherapy with recombinant grass pollen allergensJournal of Allergy and Clinical Immunology, 2005